Novo Nordisk covers its dividend, and Pfizer doesn't, but investors appear increasingly worried about Novo's future.

With around half of the United States' watch hours going to streaming today, and even less in some international markets, ...

With a forward price-to-earnings (P/E) ratio of 6.5 times fiscal 2027 analyst estimates, Micron's stock looks dirt cheap. The ...

Cameco's stock has fallen from $134 to $85, but that drop could be an opportunity for investors looking to invest in nuclear ...

Over his career, Warren Buffett established himself as one of the world's best investors. However, after 60 years at ...

At its current pace, the software giant could spend it all before 2030. What might that do to earnings per share?

And this spring, Lilly won regulatory approval for Foundayo. All three are part of a class of drugs known as GLP-1. These ...

Zepbound was a breakthrough. It became the first medicine to mimic the GLP-1 and GIP gut hormones and be approved for weight ...

Since 1945, the U.S. stock market has endured 37 corrections (declines of 10% or more), according to data from MUFG. These 10 ...

The more important figure is the running total. Through three quarters, Tesla has delivered 1,324,681 vehicles, around 9% ...

There aren’t that many public companies better equipped to deal with recessions and market crashes than this one.

MercadoLibre recently surpassed Coupang in quarterly revenue for the first time, marking a pivotal shift in their competitive ...